www.alloytx.com Open in urlscan Pro
2606:4700:20::681a:26b  Public Scan

Submitted URL: http://www.alloytx.com/
Effective URL: https://www.alloytx.com/
Submission: On February 28 via api from US — Scanned from DE

Form analysis 2 forms found in the DOM

POST /

<form method="post" enctype="multipart/form-data" id="gform_1" action="/" data-formid="1">
  <input type="hidden" class="gforms-pum" value="{&quot;closepopup&quot;:false,&quot;closedelay&quot;:0,&quot;openpopup&quot;:false,&quot;openpopup_id&quot;:0}">
  <div class="gform-body gform_body">
    <div id="gform_fields_1" class="gform_fields top_label form_sublabel_below description_below">
      <div id="field_1_1" class="gfield gfield--type-email footerInput field_sublabel_below gfield--no-description field_description_below gfield_visibility_visible" data-js-reload="field_1_1"><label class="gfield_label gform-field-label"
          for="input_1_1">Get news about the Alloy ecosystem:</label>
        <div class="ginput_container ginput_container_email">
          <input name="input_1" id="input_1_1" type="text" value="" class="large" placeholder="name@email.com" aria-invalid="false">
        </div>
      </div>
    </div>
  </div>
  <div class="gform_footer top_label"> <input type="submit" id="gform_submit_button_1" class="gform_button button" value="Submit" onclick="if(window[&quot;gf_submitting_1&quot;]){return false;}  window[&quot;gf_submitting_1&quot;]=true;  "
      onkeypress="if( event.keyCode == 13 ){ if(window[&quot;gf_submitting_1&quot;]){return false;} window[&quot;gf_submitting_1&quot;]=true;  jQuery(&quot;#gform_1&quot;).trigger(&quot;submit&quot;,[true]); }">
    <input type="hidden" class="gform_hidden" name="is_submit_1" value="1">
    <input type="hidden" class="gform_hidden" name="gform_submit" value="1">
    <input type="hidden" class="gform_hidden" name="gform_unique_id" value="">
    <input type="hidden" class="gform_hidden" name="state_1" value="WyJbXSIsIjk0MzgyZjg2Nzc4YWIyNjI0YWNmNjA3MDUzMzUzZDI4Il0=">
    <input type="hidden" class="gform_hidden" name="gform_target_page_number_1" id="gform_target_page_number_1" value="0">
    <input type="hidden" class="gform_hidden" name="gform_source_page_number_1" id="gform_source_page_number_1" value="1">
    <input type="hidden" name="gform_field_values" value="">
  </div>
</form>

POST /#gf_1

<form method="post" enctype="multipart/form-data" target="gform_ajax_frame_1" id="gform_1" action="/#gf_1" data-formid="1">
  <input type="hidden" class="gforms-pum" value="{&quot;closepopup&quot;:false,&quot;closedelay&quot;:0,&quot;openpopup&quot;:false,&quot;openpopup_id&quot;:0}">
  <div class="gform-body gform_body">
    <div id="gform_fields_1" class="gform_fields top_label form_sublabel_below description_below">
      <div id="field_1_1" class="gfield gfield--type-email footerInput field_sublabel_below gfield--no-description field_description_below gfield_visibility_visible" data-js-reload="field_1_1"><label class="gfield_label gform-field-label"
          for="input_1_1">Get news about the Alloy ecosystem:</label>
        <div class="ginput_container ginput_container_email">
          <input name="input_1" id="input_1_1" type="text" value="" class="large" placeholder="name@email.com" aria-invalid="false">
        </div>
      </div>
    </div>
  </div>
  <div class="gform_footer top_label"> <input type="submit" id="gform_submit_button_1" class="gform_button button" value="Submit" onclick="if(window[&quot;gf_submitting_1&quot;]){return false;}  window[&quot;gf_submitting_1&quot;]=true;  "
      onkeypress="if( event.keyCode == 13 ){ if(window[&quot;gf_submitting_1&quot;]){return false;} window[&quot;gf_submitting_1&quot;]=true;  jQuery(&quot;#gform_1&quot;).trigger(&quot;submit&quot;,[true]); }"> <input type="hidden" name="gform_ajax"
      value="form_id=1&amp;title=&amp;description=&amp;tabindex=0">
    <input type="hidden" class="gform_hidden" name="is_submit_1" value="1">
    <input type="hidden" class="gform_hidden" name="gform_submit" value="1">
    <input type="hidden" class="gform_hidden" name="gform_unique_id" value="">
    <input type="hidden" class="gform_hidden" name="state_1" value="WyJbXSIsIjk0MzgyZjg2Nzc4YWIyNjI0YWNmNjA3MDUzMzUzZDI4Il0=">
    <input type="hidden" class="gform_hidden" name="gform_target_page_number_1" id="gform_target_page_number_1" value="0">
    <input type="hidden" class="gform_hidden" name="gform_source_page_number_1" id="gform_source_page_number_1" value="1">
    <input type="hidden" name="gform_field_values" value="">
  </div>
  <input type="hidden" name="pum_form_popup_id" value="771">
</form>

Text Content

Join us on 12-15-2022 for a live seminar about RNA SEQ

Click Here
 * Platforms
 * Services
 * Venture Studios
 * Team
 * Media

 * Platforms
 * Services
 * Venture Studios
 * Team
 * Media


Learn more




BETTER
MEDICINE, TOGETHER

Through a community of partners, we democratize access to foundational,
pre-competitive biologics discovery technologies and services.









WE EMPOWER DISCOVERY ACROSS 6 BIOLOGIC MODALITIES


WE SUPPORT THE DRUG DISCOVERY INDUSTRY WITH 3 CORE ACTIVITIES ACROSS 6 BIOLOGIC
MODALITIES


WE EMPOWER DRUG DISCOVERY ACROSS 6 BIOLOGIC MODALITIES WITH OUR PLATFORMS,
SERVICES, AND COMPANY CREATION

We’ve grown from our original platform for human monoclonal antibody discovery,
the ATX-Gx™, to support a spectrum of biologics. Discovery groups can find the
best drug against their target and develop innovative new therapeutic formats.

We aggregate, improve, co-develop, and outlicense foundational precompetitive
drug discovery platform technologies. 

We provide services and capabilities to discover therapeutic drug candidates for
our partners.

We collaborate to build new asset-focused companies leveraging this expertise
and infrastructure.

We develop, improve, license, and share foundational, pre-competitive drug
discovery platform technologies. We provide services and support to discover
therapeutic drug candidates for our partners and the broader ecosystem. We
collaborate to build new, asset-focused companies leveraging our expertise and
infrastructure and support innovative ecosystem partners who share our mission.

--------------------------------------------------------------------------------

 



 



 



 



 



 



ANTIBODIES

TCRS

GENETIC MEDICINES

PEPTIDES

CELL THERAPIES

DELIVERY

ANTIBODIES




TCRS




GENETIC MEDICINES




ANTIBODIES




TCRS




GENETIC MEDICINES




PEPTIDES




CELL THERAPIES




DELIVERY




PEPTIDES




CELL THERAPIES




DELIVERY






OUR ECOSYSTEM MODEL TRANSFORMS DRUG DISCOVERY





WE ARE A BIOTECHNOLOGY ECOSYSTEM COMPANY

We offer our technologies and capabilities to the entire drug discovery
community—from academic scientists, small and medium biotech, to the largest
biopharma—on affordable, non-exclusive terms. This network of drug discovery
teams creates innovations and shares services that are widely available through
collaboration to benefit all.

See case studies




WE MAKE FOUNDATIONAL DRUG DISCOVERY CAPABILITIES AND TECHNOLOGIES AVAILABLE TO
ALL

We reinvest 100% of our revenue into innovation and access to innovation to
continually improve our offering for partners. Access our offerings through:




PLATFORM LICENSES





DISCOVERY SERVICES





INNOVATION SUBSCRIPTIONS







 * 
 * LICENSES
 * 

 * 
 * SERVICES
 * 

 * 
 * SUBSCRIPTION
 * 







LICENSE PRE-COMPETITIVE TECH WITHOUT RESTRICTIONS

Join the over 130 companies already working one or more of Alloy’s technologies.
We develop, improve, license, and share foundational, pre-competitive discovery
platforms and offer broad access to the global drug discovery community,
including other CROs who can support your drug discovery efforts. We have active
research and collaborations across our six modalities and currently offer broad
access to our first two modalities: Antibodies and TCRs.

Talk with Business Development





Dig into:

ANTIBODY PLATFORMS

TCR PLATFORMS







DRUG DISCOVERY & OPTIMIZATION SERVICES

If you need help beyond your current internal or CRO capabilities, we have built
one of the world’s best discovery services team conducting dozens of high-touch,
bespoke therapeutic discovery campaigns per year across Alloy’s 5 global
research sites. We can work with you in a custom and fully integrated drug
discovery approach that deploys our complete offering of proprietary in vivo, in
vitro and in silico discovery platforms combined with advanced analytics,
antigen generation, functional assay, informatics, and machine learning
capabilities to discover the best therapeutic candidate against your target of
interest.

Get started



Explore:

DEEPIMMUNE ANTIBODY DISCOVERY

KEYWAY TCR DISCOVERY

TRANSLATIONAL MEDICINE







ALL THE TECH YOU NEED, ONE FIXED PRICE

We envision a future where all Big Pharma can access cutting-edge innovations in
real-time and royalty-free to unlock the potential of internal drug discovery
teams in all companies. Our best companies shouldn’t have to wait 20 years for
patents to expire to get unfettered access to the newest pre-competitive
platforms and technologies. Alloy’s Innovation Subscriptions give unlimited
access to all our current and forthcoming technology, for a one-stop solution to
your discovery challenges. Combined with our commitment to reinvesting 100% of
our revenue back into innovation and access to innovation, this creates a
powerful flywheel of innovation for all Innovation Subscription partners.

Let's discuss Innovation Subscriptions





PRE-COMPETITIVE TECH

UNLIMITED ACCESS

FIXED ANNUAL FEE







CASE STUDIES: HOW WE HELP

There is no one-size-fits-all engagement with Alloy. We partner flexibly and
creatively across each collaboration, activating our stable of platform
technologies, discovery services, and company creation capabilities to meet our
partners’ goals.


ATX-GX™ BIOTECH LICENSEE DISCOVERING NOVEL THERAPEUTICS


PARTNERING WITH TARGET-RICH BIOTECH COMPANIES


DEMOCRATIZING ACCESS FOR ACADEMIC ENTREPRENEURS







MAKE MEDICINE TOGETHER

We empower scientists by democratizing access to foundational tools,
technologies, services, and company creation capabilities. We reduce barriers in
drug discovery to help the best treatments get to patients—faster. May the best
drug win.

SEE OUR MISSION FROM FOUNDER & CEO, ERRIK B. ANDERSON






Your consent is required to display this content from vimeo - Accept Privacy
Settings Here




Watch our mission video.





WE’LL WORK WITH YOU TO MEET YOUR DISCOVERY GOALS

By design, our model is concierge and collaborative, just like our name. We will
never have our own drug pipeline. We collaborate with our partners to leverage
the full potential of our technology and services, as an innovation engine for
the drug discovery industry. How can we help you reach your goals?

Schedule a call with Business Development







ON A MISSION TO OUT-COLLABORATE THE WORLD, TOGETHER

We are a team of 100+ people across 5 research sites, and our work is amplified
by our ecosystem of hundreds of companies and thousands of engaged researchers.



Meet our team
Explore openings





WE ARE ON A MISSION TO OUT-COLLABORATE THE WORLD, TOGETHER.

We are a team of 75+ people across 5 research sites, and our work is amplified
through our ecosystem of hundreds.

Meet our team


Explore openings







We democratize access to foundational, pre-competitive biologics discovery
technologies and services.

275 Second Ave, Suite 200, Waltham, MA 02451







Explore:

 * Platforms
 * Services
 * Venture Studios
 * Team
 * Media
 * Careers




Case Studies:


ATX-GX™ BIOTECH LICENSEE DISCOVERING NOVEL THERAPEUTICS

May 17, 2022


PARTNERING WITH TARGET-RICH BIOTECH COMPANIES

March 25, 2022


DEMOCRATIZING ACCESS FOR ACADEMIC ENTREPRENEURS

March 24, 2022


Get news about the Alloy ecosystem:





Our research facilities:




Boston, MA




Cambridge, UK




Basel, CH




San Francisco, CA




Athens, GA






© 2023 Alloy Therapeutics, Inc. All Rights Reserved. 




Privacy Policy, Terms & Conditions





Accept Privacy Settings Here
We use cookies to enhance your experience while using our website. If you are
using our Services via a browser you can restrict, block or remove cookies
through your web browser settings. We also use content and scripts from third
parties that may use tracking technologies. You can selectively provide your
consent below to allow such third party embeds. For complete information about
the cookies we use, data we collect and how we process them, please read and
Privacy Policy
Youtube
Consent to display content from Youtube

Vimeo
Consent to display content from Vimeo

Google Maps
Consent to display content from Google

Spotify
Consent to display content from Spotify

Sound Cloud
Consent to display content from Sound

Save
We use cookies to enhance your experience while using our website. To learn more
about the cookies we use and the data we collect, please read and Accept Privacy
Settings Here.
I Accept
 * Platforms
 * Services
 * Venture Studios
 * Team
 * Media





X

X

X

X
Get news about the Alloy ecosystem:


×

Notifications